Martin Hunt
Président chez SKINBIOTHERAPEUTICS PLC
Fortune : 64 140 $ au 30/04/2024
Profil
Martin Braddock Hunt is currently the Chairman of Videregen Ltd., the Non-Executive Chairman of SkinBioTherapeutics Plc, the Programme Director of i4i LP, a Director of Invictus Management Ltd., and a Programme Director of the National Institute for Health & Care Research.
Previously, he was the Chief Executive Officer of Tissue Science Laboratories Ltd., the Deputy Chairman of MDY Healthcare Ltd., the Vice Chairman-Supervisory Board of Trophos SA, the Marketing Director-Europe, Middle East & Africa of Wyeth Holdings LLC, a Director of ArcticZymes Technologies ASA, a Director of DYSIS Medical Ltd., a Director of Tissue Science Laboratories (UK) Ltd., a Director of Regentix Ltd., a Non-Executive Director of Orthox Ltd., and the Vice President-Europe Sales of Bristol Myers Squibb Co.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SKINBIOTHERAPEUTICS PLC
0,28% | 30/06/2023 | 560 417 ( 0,28% ) | 64 140 $ | 30/04/2024 |
Postes actifs de Martin Hunt
| Sociétés | Poste | Début |
|---|---|---|
| SKINBIOTHERAPEUTICS PLC | Président | 03/10/2016 |
Invictus Management Ltd.
 Invictus Management Ltd. Miscellaneous Commercial ServicesCommercial Services Invictus Management Ltd. is an Irish private company located in Dublin that provides business and management consulting services. | Directeur/Membre du Conseil | 13/12/2010 |
National Institute For Health & Care Research
 National Institute For Health & Care Research Miscellaneous Commercial ServicesCommercial Services National Institute for Health Research improves the health and wealth of the nation through research. It provides support for applied health research focused on the needs of patients and the public. The company was founded in April 2006 and is headquartered in Middlesex, the United Kingdom. | Corporate Officer/Principal | - |
| i4i LP | Corporate Officer/Principal | - |
Videregen Ltd.
 Videregen Ltd. BiotechnologyHealth Technology Videregen Ltd. operates a regenerative medicine company created to address the chronic shortage of organs for transplantation in the field of tissue decellularisation, regenerative technologies and translation from laboratory to market. Its platform technology uses decellularised organ scaffolds seeded with the patient’s own cells to create non-immunogenic, regenerative bespoke organ replacements. The company was founded by Stephen Bloor in 2011 and is headquartered in Liverpool, The United Kingdom. | Président | - |
Anciens postes connus de Martin Hunt
| Sociétés | Poste | Fin |
|---|---|---|
| Tissue Science Laboratories (UK) Ltd. | Directeur/Membre du Conseil | - |
| ARCTICZYMES TECHNOLOGIES ASA | Directeur/Membre du Conseil | - |
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Directeur/Membre du Conseil | - |
DYSIS Medical Ltd.
 DYSIS Medical Ltd. Medical SpecialtiesHealth Technology DySIS Medical Ltd. designs, develops, manufactures, and markets medical imaging systems. Its imaging systems assist clinicians with non-invasive, in-vivo detection of cancerous and pre-cancerous lesions and provides tools to aid medical practitioners in the detection, grading, and documentation of cervical neoplasia. The company was founded by Costas Balas in 2002 and is headquartered in Livingston, the United Kingdom. | Président | - |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| SKINBIOTHERAPEUTICS PLC | Health Technology |
| ARCTICZYMES TECHNOLOGIES ASA | Health Technology |
| Entreprise privées | 12 |
|---|---|
Tissue Science Laboratories Ltd.
 Tissue Science Laboratories Ltd. Medical SpecialtiesHealth Technology Tissue Science Laboratories Ltd. develops and markets tissue implant products. The company was founded on January 7, 1999 and is headquartered in Watford, the United Kingdom. | Health Technology |
MDY Healthcare Ltd.
 MDY Healthcare Ltd. Financial ConglomeratesFinance MDY Healthcare Ltd. engaged in the provision of healthcare products. It offered a diabetes management, and medical safety products. The company was founded in 1984 and was headquartered in Guildford, the United Kingdom. | Finance |
| Tissue Science Laboratories (UK) Ltd. | |
| Regentix Ltd. | |
Invictus Management Ltd.
Invictus Management Ltd. Miscellaneous Commercial ServicesCommercial Services Invictus Management Ltd. is an Irish private company located in Dublin that provides business and management consulting services. | Commercial Services |
Orthox Ltd.
 Orthox Ltd. BiotechnologyHealth Technology Orthox Ltd. develops tissue regenerative implants. The firm?s products include FibroFix Meniscus and FibroFix Cartilage. The company was founded by Nicholas James Vavasour Skaer and Oliver Kessler in 2008 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Wyeth Holdings LLC
 Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. | Process Industries |
National Institute For Health & Care Research
National Institute For Health & Care Research Miscellaneous Commercial ServicesCommercial Services National Institute for Health Research improves the health and wealth of the nation through research. It provides support for applied health research focused on the needs of patients and the public. The company was founded in April 2006 and is headquartered in Middlesex, the United Kingdom. | Commercial Services |
DYSIS Medical Ltd.
DYSIS Medical Ltd. Medical SpecialtiesHealth Technology DySIS Medical Ltd. designs, develops, manufactures, and markets medical imaging systems. Its imaging systems assist clinicians with non-invasive, in-vivo detection of cancerous and pre-cancerous lesions and provides tools to aid medical practitioners in the detection, grading, and documentation of cervical neoplasia. The company was founded by Costas Balas in 2002 and is headquartered in Livingston, the United Kingdom. | Health Technology |
| i4i LP | |
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Health Technology |
Videregen Ltd.
Videregen Ltd. BiotechnologyHealth Technology Videregen Ltd. operates a regenerative medicine company created to address the chronic shortage of organs for transplantation in the field of tissue decellularisation, regenerative technologies and translation from laboratory to market. Its platform technology uses decellularised organ scaffolds seeded with the patient’s own cells to create non-immunogenic, regenerative bespoke organ replacements. The company was founded by Stephen Bloor in 2011 and is headquartered in Liverpool, The United Kingdom. | Health Technology |